Fuji Pharma Co Ltd (4554) Stock Price & News

Q4 2026 earnings • released • Revenue miss -3.49%

See results

4554:TYO

Fuji Pharma Co Ltd

¥1,886.00

+2.78%

(+51.00) 1D

Nov 10, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4554...

Open

¥1,854

High

¥1,904

Low

¥1,842

Mkt. cap

50.06B

Avg. vol.

126.34K

Volume

218.20K

Dividend

2.41%

Quarterly dividend

¥11

Ex-dividend date

Sep 29, 2026

P/E ratio

15.85

52-wk high

¥2,559

52-wk low

¥1,550

EPS

¥119

Shares outstanding

29.92M

No. of employees

Open

¥1,854

High

¥1,904

Low

¥1,842

Mkt. cap

50.06B

Avg. vol.

126.34K

Volume

218.20K

Dividend

2.41%

Quarterly dividend

¥11

Ex-dividend date

Sep 29, 2026

P/E ratio

15.85

52-wk high

¥2,559

52-wk low

¥1,550

EPS

¥119

Shares outstanding

29.92M

No. of employees

Related stocks

4553

Towa Pharmaceutical Co Ltd

¥3,505.00

+3.85%

4887

Sawai Group Holdings Co Ltd

¥1,690.00

+1.81%

4577

Daito Pharmaceutical Co Ltd

¥1,308.00

0.00%

4539

Nippon Chemiphar Co Ltd

¥1,470.00

+0.34%

News stories

From web sources and news partners

TradingView

8 hours ago

Fuji Pharma Co Ltd : Sales and operating profit advanced, but investment losses weighed on FY26 net income

About Fuji Pharma Co Ltd

CEO-

Employees1.76K

FoundedApr 1, 1965

Headquarters-

SectorHealth Care

IndustryPharmaceutical industry

Websitefujipharma.jp

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	14.72B	15.90B	13.82B	15.67B
Cost of goods sold	8.71B	9.08B	8.30B	10.33B
Cost of revenue	8.71B	9.08B	8.30B	10.33B
Research and development expenses	3.34B	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-428.00M	4.03B	3.90B	4.34B
Operating expense	4.39B	4.03B	3.90B	4.34B
Total operating expenses	13.10B	13.11B	12.21B	14.67B
Operating income	1.62B	2.79B	1.61B	995.00M
Other non operating income	68.00M	-47.00M	139.00M	222.00M
EBT including unusual items	1.30B	195.00M	489.00M	1.43B
EBT excluding unusual items	1.63B	2.65B	1.68B	1.22B
Income tax expense	133.00M	-129.00M	100.00M	320.00M
Effective tax rate	10.21%	-66.15%	20.45%	22.42%
Other operating expenses	-	-	-	-
Net income	1.17B	324.00M	389.00M	1.11B
Net profit margin	7.95%	2.04%	2.81%	7.07%
Earnings per share	-	-	-	-
Interest and investment income	-	-	1.00M	1.00M
Interest expense	-100.00M	-84.00M	-105.00M	-98.00M
Net interest expenses	-100.00M	-84.00M	-104.00M	-97.00M
Depreciation and amortization charges	1.38B	-	-	-
EBITDA	2.61B	3.78B	2.64B	1.99B
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything